TITLE

HIV Prevention in Care and Treatment Settings: Baseline Risk Behaviors among HIV Patients in Kenya, Namibia, and Tanzania

AUTHOR(S)
Kidder, Daniel P.; Bachanas, Pam; Medley, Amy; Pals, Sherri; Nuwagaba-Biribonwoha, Harriet; Ackers, Marta; Howard, Andrea; DeLuca, Nick; Mbatia, Redempta; Sheriff, Muhsin; Arthur, Gilly; Katuta, Frieda; Cherutich, Peter; Somi, Geoffrey
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
HIV care and treatment settings provide an opportunity to reach people living with HIV/AIDS (PLHIV) with prevention messages and services. Population-based surveys in sub-Saharan Africa have identified HIV risk behaviors among PLHIV, yet data are limited regarding HIV risk behaviors of PLHIV in clinical care. This paper describes the baseline sociodemographic, HIV transmission risk behaviors, and clinical data of a study evaluating an HIV prevention intervention package for HIV care and treatment clinics in Africa. The study was a longitudinal group-randomized trial in 9 intervention clinics and 9 comparison clinics in Kenya, Namibia, and Tanzania (N = 3538). Baseline participants were mostly female, married, had less than a primary education, and were relatively recently diagnosed with HIV. Fifty-two percent of participants had a partner of negative or unknown status, 24% were not using condoms consistently, and 11% reported STI symptoms in the last 6 months. There were differences in demographic and HIV transmission risk variables by country, indicating the need to consider local context in designing studies and using caution when generalizing findings across African countries. Baseline data from this study indicate that participants were often engaging in HIV transmission risk behaviors, which supports the need for prevention with PLHIV (PwP). Trial Registration: ClinicalTrials.gov NCT01256463
ACCESSION #
87625296

 

Related Articles

  • Study of patients diagnosed with advanced HIV in the HAART era – OMEGA Cohort. Santos, J.; Palacios, R.; Ruiz, J.; González, M.; Márquez, M. // International Journal of STD & AIDS;Mar2005, Vol. 16 Issue 3, p252 

    Our objective is to analyse patients diagnosed with late-stage HIV infection in the highly active antiretroviral therapy (HAART) area. A prospective, observational study of all patients with an initial CD4<50 × 106/L was carried out. Epidemiological, clinical and HAART-associated data were...

  • Determinants of knowledge of HIV status in South Africa: results from a population-based HIV survey. Peltzer, Karl; Matseke, Gladys; Mzolo, Thembile; Majaja, Mmapaseka // BMC Public Health;2009, Vol. 9 Issue 1, p1 

    Background: Over 30% of women and men in the South African national HIV household of 2005 indicated that they had previously been tested for HIV (of which 91% were aware of their test results). This paper seeks to describe the associations between socio-demographic, behavioural and social...

  • Comparative effectiveness of tenofovir in treatment-naïve HIV-infected patients: systematic review and meta-analysis. Hemkens, Lars G.; Ewald, Hannah; Santini-Oliveira, Marilia; Bühler, Julian-Emanuel; Vuichard, Danielle; Schandelmaier, Stefan; Stöckle, Marcel; Briel, Matthias; Bucher, Heiner C. // HIV Clinical Trials;Oct2015, Vol. 16 Issue 5, p178 

    Introduction: Benefits and harms of tenofovir disoproxil fumarate (TDF) in HIV-infected, antiretroviral treatment (ART)-naïve patients of any age have not been systematically reviewed since recent milestone trials were published. Methods: We searched MEDLINE, EMBASE, CENTRAL, SCI, LILACS, WHO...

  • THE ALIVE STUDY: A LONGITUDINAL STUDY OF HIV-1 INFECTION IN INTRAVENOUS DRUG USERS: DESCRIPTION OF METHODS. Vlahov, David; Anthony, James C.; Mu�oz, Alvaro; Margolick, Joseph; Nelson, Kenrad E.; Celentano, David D.; Solomon, Liza; Polk, B. Frank // Journal of Drug Issues;Fall91, Vol. 21 Issue 4, p759 

    To identify risk factors for infection with the human immunodeficiency virus (HIV) and for progression to the acquired immunodeficiency syndrome (AIDS) among intravenous drug users, we established a cohort in Baltimore Maryland in 1988-1989. Intravenous drug users were recruited by extensive...

  • Correlates of late HIV diagnosis: implications for testing policy. Delpierre, Cyrille; Dray-Spira, Rosemary; Cuzin, Lise; Marchou, Bruno; Massip, Patrice; Lang, Thierry; Lert, France // International Journal of STD & AIDS;May2007, Vol. 18 Issue 5, p312 

    To develop new strategies aimed to reduce the delay in seeking HIV diagnosis, we proposed to identify correlates of late diagnosis of HIV infection in France. Late testing was studied among the 1077 patients diagnosed from 1996 and enrolled in the ANRS-EN12-VESPA, a representative sample of the...

  • Mandatory HIV testing in China: the perception of health-care providers. Li Li; Zunyou Wu; Sheng Wu; Sung-Jae Lee; Rotheram-Borus, Mary Jane; Detels, Roger; Manhong Jia; Sun, Stephanie // International Journal of STD & AIDS;Jul2007, Vol. 18 Issue 7, p476 

    Health-care providers in China are facing an exponential increase in HIV testing and HIV-positive patients. A total of 1101 service providers were recruited to examine attitudes toward people living with HIV/AIDS (PLWHA) in China. Logistic regression models were used to assess factors associated...

  • Effect of Suppressing HIV Viremia on the HIV Progression of Patients Undergoing a Genotype Resistance Test after Treatment Failure. Zaccarelli, M.; Lorenzini, P.; Tozzi, V.; Forbici, F.; Ceccherini-Silberstein, F.; Gori, C.; D’Arrigo, R.; Trotta, M.; Narciso, P.; Perno, C.; Antinori, A. // Infection;Jun2009, Vol. 37 Issue 3, p203 

    Treatment guidelines for multi-experienced HIV patients have recently evolved from aiming to preserve immunity to achieving virological success, largely due to the availability of new antiretroviral drugs and drug classes. To assess the role of viral suppression on clinical progression following...

  • Correlates of perceived risk of HIV infection among persons who inject drugs in Tijuana, Baja California, Mexico. Armenta, Richard F.; Abramovitz, Daniela; Lozada, Remedios; Vera, Alicia; Garfein, Richard S.; Magis-Rodríguez, Carlos; Strathdee, Steffanie A. // Salud Pública de México;2015 Supplement, Vol. 57, pS107 

    Objective. We identified correlates of perceived risk of HIV infection among persons who inject drugs (PWID) in Tijuana. Materials and methods. PWID ≥18 years of age who injected drugs in the past month were recruited between 2006-2007 and completed risk assessment interviews and serologic...

  • Estimated Lifetime Risk for Diagnosis of HIV Infection Among Hispanics/Latinos -- 37 States and Puerto Rico, 2007. Adih, W. K.; Hu, X.; Campsmith, M. L.; Espinoza, L.; Hall, H. I. // MMWR: Morbidity & Mortality Weekly Report;10/15/2010, Vol. 59 Issue 40, p1297 

    The article reports on the result of a study on HIV infection among the Hispanic American population in the U.S. which is conducted by the U.S. Centers for Disease Prevention and Control (CDC). The study considers the annual rate of diagnosis with HIV infection, based on computations of the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics